HCDCP

Novel Coronavirus COVID-19 Advice for travellers

,
|
08.03.2023

On the 31st December 2019, the World Health Organization was informed of a cluster of pneumonia of unknown cause in Wuhan in Hubei province, China. On January 9th, 2020, a novel coronavirus (2019-nCoV) was identified as a cause. Corona viruses are a group of viruses that usually cause respiratory infections of varying severity to humans and animals.  It is estimated that almost one third of infections of the upper respiratory system in humans can be caused by corona viruses.

The overwhelming majority of cases have been reposted in China. The novel coronavirus (2019-nCoV) is transmitted from human-to-human. Transmission has also been documented in health professionals. Infection caused by the novel coronavirus (2019-nCoV) can manifest with fever, cough, and shortness of breath, sore throat and in serious cases with pneumonia.

Confirmed cases have been reported worldwide, in Asia, the Middle East, Europe as well as in the United States of America, Canada and Australia. According to World Health Organization there are no travel restrictions up to this date.

 

Advice for travellers

The risk for travellers is considered moderate. It is recommended that travellers avoid nonessential travel to areas with presumed ongoing community transmission of COVID-19 (https://www.ecdc.europa.eu/en/areas-presumed-ongoing-community-transmission-2019-ncov).  There is no vaccine against this novel corona virus.

               

If you are travelling to areas with presumed ongoing community transmission of COVID-19 you should:

 

During your stay in areas with presumed ongoing community transmission of COVID-19 you should:

 

After your return from areas with presumed ongoing community transmission of COVID-19:

 

Useful Links